This episode features Yuri Fesko MD, with clinical pathways to help guide diagnosis and treatment in oncology. In this session, Dr Fesko discusses:
How clinical pathways can make an impact for hospitals to improve oncology outcomes
The critical importance of collaboration for pathologists and oncologists
The future of oncology care in integrated health systems
Yuri Fesko MD Bio:
Dr Yuri Fesko serves as the Executive Medical Director of Medical Affairs at Quest Diagnostics, and the Chief Clinical Officer for Oncology Strategic Collaboration at Quest. Born and raised in New York City, Dr Fesko trained at Case Western Reserve University, and completed his fellowship at University Hospitals of Cleveland. After his fellowship, Dr Fesko served as the Chief of Community Oncology for Wake County through Duke University Health System.An experienced oncologist and medical business leader, he is currently responsible for strategic clinical development at Quest across multiple functional areas including Regulatory FDA, HEOR, and R&D.
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
To leave or reply to comments, please download free Podbean or
To leave or reply to comments, please download free Podbean App.